Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bright Shift
Manchester, England, United Kingdombrightshiftinc.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Bright Biotech has developed a proprietary plant chloroplast expression platform to produce high-quality recombinant proteins—especially growth factors—at scale. Their technology aims to reduce costs and improve sustainability in the production of cultivated meat, cell therapies, and regenerative medicine products. The company has raised $3.33M in seed funding and is moving toward rapid commercialization with first products expected on the market from 2023 onward. No clinical trial results are reported as their main focus is enabling technologies rather than direct therapeutic development.
- Therapeutic areas
- Other
- Modalities
- Recombinant proteinGrowth factorProtein (general category)
- Industry
- Non-Drug Biotech
02
Partnerships
Supported by accelerators such as EIT Food Accelerator NetworkBig Idea Ventures AcceleratorGROW Accelerator
Beyond the preview
Go deeper on Bright Shift.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bright Shift.